1
|
Iorio L, Davanzo F, Cazzador D, Codirenzi M, Fiorin E, Zanatta E, Nicolai P, Doria A, Padoan R. Cocaine- and Levamisole-Induced Vasculitis: Defining the Spectrum of Autoimmune Manifestations. J Clin Med 2024; 13:5116. [PMID: 39274328 PMCID: PMC11396482 DOI: 10.3390/jcm13175116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2024] [Revised: 08/16/2024] [Accepted: 08/23/2024] [Indexed: 09/16/2024] Open
Abstract
Drug-induced or associated vasculitis is a prevalent form of vasculitis that resembles primary idiopathic antineutrophil cytoplasmic autoantibody (ANCA) vasculitis (AAV). Cocaine is a diffuse psychostimulant drug and levamisole is a synthetic compound used to cut cocaine. Their abuse may result in a spectrum of autoimmune manifestations which could be categorized into three overlapping clinical pictures: cocaine-induced midline destructive lesion (CIMDL), levamisole-adulterated cocaine (LAC) vasculopathy/vasculitis, and cocaine-induced vasculitis (CIV). The mechanisms by which cocaine use leads to disorders resembling AAV are not well understood. Cocaine can cause autoimmune manifestations ranging from localized nasal lesions to systemic diseases, with neutrophils playing a key role through NETosis and ANCA development, which exacerbates immune responses and tissue damage. Diagnosing and treating these conditions becomes challenging when cocaine and levamisole abuse is not suspected, due to the differences and overlaps in clinical, diagnostic, therapeutic, and prognostic aspects compared to primary idiopathic vasculitides.
Collapse
Affiliation(s)
- Luca Iorio
- Rheumatology Unit, Department of Medicine DIMED, University of Padua, 35128 Padua, Italy
| | - Federica Davanzo
- Rheumatology Unit, Department of Medicine DIMED, University of Padua, 35128 Padua, Italy
| | - Diego Cazzador
- Otorhinolaryngology Section, Department of Neuroscience DNS, University of Padua, 35128 Padua, Italy
| | - Marta Codirenzi
- Rheumatology Unit, Department of Medicine DIMED, University of Padua, 35128 Padua, Italy
| | - Eleonora Fiorin
- Rheumatology Unit, Department of Medicine DIMED, University of Padua, 35128 Padua, Italy
| | - Elisabetta Zanatta
- Rheumatology Unit, Department of Medicine DIMED, University of Padua, 35128 Padua, Italy
- Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35128 Padova, Italy
| | - Piero Nicolai
- Otorhinolaryngology Section, Department of Neuroscience DNS, University of Padua, 35128 Padua, Italy
| | - Andrea Doria
- Rheumatology Unit, Department of Medicine DIMED, University of Padua, 35128 Padua, Italy
| | - Roberto Padoan
- Rheumatology Unit, Department of Medicine DIMED, University of Padua, 35128 Padua, Italy
| |
Collapse
|
2
|
Viedma-Martinez M, Gallo-Pineda G, Recio-Monescillo M, Jimenez-Gallo D, Lopez-Sanz P, Drake-Monfort M, Urigoitia-Ugalde P, Martínez-Signes V, Llorca-Juan D, Fuertes-Vega L, Ríos-Viñuela E, Escario-Travesedo E, Ríos-Martín JJ, Requena-Caballero L, Linares-Barrios M. Retrospective Case Series of Cocaine-Associated Plasma Cell Orificial Mucositis. JAMA Dermatol 2024; 160:320-327. [PMID: 38265770 PMCID: PMC10809139 DOI: 10.1001/jamadermatol.2023.5692] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2023] [Accepted: 11/15/2023] [Indexed: 01/25/2024]
Abstract
Importance Plasma cell orificial mucositis (PCOM) associated with cocaine use is an emerging, rare condition that has become a concern in Spain in recent years. Limited knowledge exists regarding this novel condition. Objectives To delineate the clinicopathologic characteristics of this emerging entity and establish a novel approach in the differential diagnosis of cocaine-associated lesions. Design, Setting, and Participants A descriptive, retrospective, multicenter case series of 10 patients diagnosed with cocaine-associated PCOM was conducted in Spain from April 2020 to March 2023. Main Outcomes and Measures Patient demographic, clinical, histopathologic, and treatment data were collected. Results A total of 10 patients (6 [60%] male; median [range] age, 45.5 [36-66] years) presenting with exudative ulcerated plaques were identified for this study. The lesions had raised and erythematous edges over the nostril and a median (range) evolution time of 9 (2-24) months. Septal or palate perforations were observed in 4 (40%) of the patients. Biopsies revealed a dense inflammatory infiltrate of plasma cells in the dermis without atypia and with eosinophils. All patients reported recent cocaine use. Three urine tests detected cocaine but found no presence of amphetamines or opiates. Six patients improved with corticosteroid therapy. Up to 60% of patients were lost to follow-up. Conclusions and Relevance This case series describes the clinicopathologic characteristics of PCOM, an emerging entity associated with cocaine use in Spain, and demonstrates a novel approach in the differential diagnosis of cocaine-associated lesions. To date, cocaine-associated skin lesions have been reported as neutrophilic dermatoses and vasculitis. The appearance of a plasma cell infiltrate changes what has been described in the medical literature so far. PCOM is a benign condition of unknown cause characterized by a proliferative polyclonal plasma cell infiltrate. A comprehensive differential diagnosis workup is required to reach this exclusionary diagnosis. Several irritants have been documented in cases of PCOM, and a hypersensitivity mechanism has been proposed. Since the initial report of cocaine-associated PCOM in Spain, its incidence has experienced a surge in the country. The cause of this phenomenon may be attributed to newly unidentified adulterants. The administration of corticosteroids and discontinuation of cocaine use are the sole treatments that have demonstrated efficacy. Clinicians should be vigilant regarding this emerging condition and conduct inquiries into cocaine use. Additional research is required to clarify the pathophysiology of this emerging condition.
Collapse
Affiliation(s)
- Myriam Viedma-Martinez
- Department of Dermatology, Hospital Universitario Puerta del Mar, Cádiz, Andalucía, Spain
| | - Gonzalo Gallo-Pineda
- Department of Dermatology, Hospital Universitario Puerta del Mar, Cádiz, Andalucía, Spain
| | - Miguel Recio-Monescillo
- Department of Dermatology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Madrid, Spain
| | - David Jimenez-Gallo
- Department of Dermatology, Hospital Universitario Puerta del Mar, Cádiz, Andalucía, Spain
| | - Pablo Lopez-Sanz
- Department of Dermatology, Hospital General Universitario De Albacete, Albacete, Castilla La Mancha, Spain
| | - Marta Drake-Monfort
- Department of Dermatology, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
| | | | | | - David Llorca-Juan
- Department of Dermatology, Hospital Universitario De La Ribera, Alzira, Valencia, Spain
| | - Laura Fuertes-Vega
- Department of Dermatology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Madrid, Spain
| | - Elisa Ríos-Viñuela
- Department of Dermatology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Madrid, Spain
| | - Eduardo Escario-Travesedo
- Department of Dermatology, Hospital General Universitario De Albacete, Albacete, Castilla La Mancha, Spain
| | - Juan José Ríos-Martín
- Pathology Department, Hospital Universitario Virgen Macarena, Sevilla, Andalucía, Spain
| | - Luis Requena-Caballero
- Department of Dermatology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Madrid, Spain
| | - Mario Linares-Barrios
- Department of Dermatology, Hospital Universitario Puerta del Mar, Cádiz, Andalucía, Spain
| |
Collapse
|